← SynDRA
VIMSELTINIB
SynDRA canonical compound SYN0040450 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | CSF1R |
|---|
| Mechanism of action | csf1r inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- CSF1R INHIBITOR
- KIT INHIBITOR
- PDGFRA INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- PTK6
- PDGFRB
- LCK
- FLT3
- ABL1
- AURKA
- MAPK1
- KCNH2
- GSK3B
- FGFR2
- CYP3A4
- CYP2D6
- CYP2C9
- CYP2C19
- CYP1A2
- CSNK1D
- CDK2
- BRPF1
- BRD4
- TRIM24
Cross-references
Synonyms
- ROMVIMZA
- Romvimza
- DCC-3014
- DP-6865
- UNII-PX9FTM69BF
- PX9FTM69BF
- DCC3014
- Vimseltinib [INN]
- SCHEMBL16047448
- GTPL11190
- EX-A4700
- NSC828316
- NSC-828316
- example 10 [WO2014145025A2]
- HY-136256
- CS-0121044
- DCC 3014
- Vimseltinib [USAN]
- VIMSELTINIB [WHO-DD]
- compound 20 [PMID: 35961460]
- compound 20 (PMID: 35961460)
- example 10 (WO2014145025A2)
- RefChem:194257
- CSF1R Inhibitor DCC-3014
- MFCD32858282
- Vimseltinib (USAN/INN)
- Vimseltinib [USAN:INN]
- DCC-3014(Vimseltinib)?
- orb1309886
- SCHEMBL30453793
- YQF2536
- TVGAHWWPABTBCX-UHFFFAOYSA-N
- BDBM50589669
- WHO 11443
- AKOS040732693
- EBC-415078
- AC-37103
- DA-72595
- MS-27682
Look up VIMSELTINIB in the interactive SynDRA portal →